| Financial Year |
March 31 2023 |
| Monetary Funds |
3,449,949,004.31 |
| Held-for-trading Financial Assets |
484,724,033.96 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,907,877,667.11 |
| Advances to Suppliers |
316,635,338.01 |
| Other Receivables |
768,831,816.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
48,512,952,767.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
766,232,728.07 |
| Total Current Assets |
56,207,485,826.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,998,902,720.37 |
| Investment Properties |
6,810,964,231.80 |
| Fixed Assetes |
232,415,751.17 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
417,906,120.34 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
8,712,230.16 |
| Deferred Income Tax Assets |
733,419,720.11 |
| Other Non-Current Assets |
2,121,027,741.22 |
| Sub-Total of Non-Current Assets |
15,964,119,367.14 |
| Total Assets |
72,171,605,193.52 |
| Short-Term Loans |
2,694,748,766.08 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
4,022,522,495.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
9,210,212.69 |
| Taxes Payable |
1,570,779,328.04 |
| Interest Payable |
-- |
| Dividend Payable |
9,105,738.68 |
| Other payables |
741,450,953.58 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,600,666,584.94 |
| Other Current Liabilities |
34,878,627.08 |
| Sub-Total of Current Liabilities |
11,342,774,146.20 |
| Long-term Loans |
27,309,160,302.93 |
| Bonds Payable |
10,707,012,657.29 |
| Long-Term Accounts Payable |
17,345,504.80 |
| Special Payable |
-- |
| Estimatied Liabilities |
685,671,993.14 |
| Deferred Income Tax Liabilities |
345,117,428.56 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,106,135,830.66 |
| Total Liabilities |
50,448,909,976.86 |
| Paid-In Capital(Or Share Stock) |
2,529,575,634.00 |
| Capital Surplus |
1,537,445,529.97 |
| Surplus Reserve |
2,427,287,916.18 |
| LESS:Treasury Stock |
99,999,682.73 |
| Undistributed Profits |
14,346,928,865.99 |
| Minority Stockholder's Interest |
967,877,891.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
20,754,817,325.29 |
| Owner's Equity（Stockholder's Equity） |
21,722,695,216.66 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
72,171,605,193.52 |
